8435 related articles for article (PubMed ID: 2159436)
1. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
3. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
4. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
[TBL] [Abstract][Full Text] [Related]
5. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
[TBL] [Abstract][Full Text] [Related]
6. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT
J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.
Knuth A; Wölfel T; Klehmann E; Boon T; Meyer zum Büschenfelde KH
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2804-8. PubMed ID: 2784858
[TBL] [Abstract][Full Text] [Related]
8. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions.
Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G
Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714
[TBL] [Abstract][Full Text] [Related]
9. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
10. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
[TBL] [Abstract][Full Text] [Related]
11. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
12. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
13. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
Gervois N; Heuze F; Diez E; Jotereau F
Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794
[TBL] [Abstract][Full Text] [Related]
14. Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.
Degiovanni G; Lahaye T; Hérin M; Hainaut P; Boon T
Eur J Immunol; 1988 May; 18(5):671-6. PubMed ID: 2967757
[TBL] [Abstract][Full Text] [Related]
15. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
Chen BP; DeMars R; Hank JA; Sondel PM
Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
Long HM; Zuo J; Leese AM; Gudgeon NH; Jia H; Taylor GS; Rickinson AB
Blood; 2009 Jul; 114(4):807-15. PubMed ID: 19443664
[TBL] [Abstract][Full Text] [Related]
17. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes.
Pandolfino MC; Viret C; Gervois N; Guilloux Y; Davodeau F; Diez E; Jotereau F
Eur J Immunol; 1992 Jul; 22(7):1795-802. PubMed ID: 1623924
[TBL] [Abstract][Full Text] [Related]
18. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
Itoh K; Platsoucas CD; Balch CM
J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.
Bernhard H; Karbach J; Wölfel T; Busch P; Störkel S; Stöckle M; Wölfel C; Seliger B; Huber C; Meyer zum Büschenfelde KH
Int J Cancer; 1994 Dec; 59(6):837-42. PubMed ID: 7989126
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
